Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Axatilimab by Incyte for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Axatilimab is under clinical development by Incyte and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData,...
Data Insights
Axatilimab by Incyte for Solid Tumor: Likelihood of Approval
Axatilimab is under clinical development by Incyte and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...